SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001654954-24-006916
Filing Date
2024-05-24
Accepted
2024-05-24 16:31:17
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A tenx_defa14a.htm DEFA14A 11949
2 tenx_defa14aimg2.jpg GRAPHIC 6352
  Complete submission text file 0001654954-24-006916.txt   22188
Mailing Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517
Business Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517 919-855-2100
TENAX THERAPEUTICS, INC. (Filer) CIK: 0000034956 (see all company filings)

IRS No.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-34600 | Film No.: 24984952
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)